# OSELTAMIVIR PHOSPHATE
> **ANDA217467** · Abbreviated New Drug Application (Generic) · Sponsor: INVAGEN PHARMS · Approved 2023-10-03
## Drug
- **FDA Application Number:** ANDA217467
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** OSELTAMIVIR PHOSPHATE
- **Generic name:** OSELTAMIVIR PHOSPHATE
- **Active ingredients:** OSELTAMIVIR PHOSPHATE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** INVAGEN PHARMS
- **Manufacturer:** Exelan Pharmaceuticals, Inc.
- **First approval:** 2023-10-03
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217467)
---
*MORVS · CC0 1.0*